Samiksha Jaiswal (Editor)

Dihydrofolate reductase inhibitor

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Dihydrofolate reductase inhibitor

A dihydrofolate reductase inhibitor (DHFR inhibitor) is a molecule that inhibits the function of dihydrofolate reductase, and is a type of antifolate.

Since folate is needed by rapidly dividing cells to make thymine, this effect may be used to therapeutic advantage. For example, methotrexate is used as cancer chemotherapy because it can prevent neoplastic cells from dividing. Bacteria also need DHFR to grow and multiply and hence inhibitors selective for bacterial vs. host DHFR have found application as antibacterial agents.

Classes of small-molecules employed as inhibitors of dihydrofolate reductase include diaminoquinazoline & diaminopyrroloquinazoline, diaminopyrimidine, diaminopteridine and diaminotriazines. The examples provided below are specific molecules belonging to one of the above-mentioned classes.

A variety of drugs act as inhibitors of dihydrofolate reductase:

  • the experimental antimalarial and anti-toxoplasmosis compound JPC-2056
  • Oral piritrexim, a treatment for metastatic urothelial cancer.
  • References

    Dihydrofolate reductase inhibitor Wikipedia